Clinical Trial Disclosure: Towards a More Transparent World
Oct 1 2013 8:30AM - Oct 2 2013 3:30PM | Hyatt Regency Bethesda
One Bethesda Metro Center
7400 Wisconsin Avenue
Bethesda, MD 20814-5326
Drug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102.
As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard. Drug Information Association is authorized by IACET to up to 1.9 CEUs for this program and tutorials. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
These programs are part of DIA’s Certificate Program and are awarded the following:
• Clinical Research Certificate Program: 8 Elective Units
>• Regulatory Affairs Certificate Program: 8 Elective Units
For more information go to www.diahome.org/certificateprograms
|Clinical Trial Disclosure Tutorial 2
|Clinical Trial Disclosure Tutorial 1
|Clinical Trial Disclosure
It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.
Statement of Credit:
If you would like to receive a statement of credit, you must attend the program and tutorial(s), if applicable, scan your name badge at the DIA registration desk each day of the program/tutorial, and complete the on-line credit request process through My Transcript at www.diahome.org. To access My Transcript, please go to www.diahome.org, select “Login to My DIA” and you will be prompted for your user ID and password. Select “My Transcript” (left side bar) and “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on October 16, 2013.
To view DIA’s grievance policy, please visit the CE page on the DIA website at www.diahome.org/CE
The Clinical Trial Disclosure meeting offers interested companies the opportunity to exhibit with a tabletop display.
Tabletop Fee: $1,500
- One six-foot skirted table
- One chair
- Standard electricity
Each tabletop rental requires at least one registered attendee to staff the table. All tabletop staff must be registered conference attendees.
Tabletop Exhibit Dates:
October 1-2, 2013
- PharmaCM by Deloitte Analytics
- SEC Associates, Inc.
- Charitable Nonprofit/Academia Member
- Member Government
- Member Standard
- Charitable Nonprofit/Academia Nonmember
- NonMember Government
- NonMember Standard
Registration Fees for Additional Offerings
- Clinical Trial Disclosure Tutorial 1 - Standard Rate
- Clinical Trial Disclosure Tutorial 2 - Standard Rate
Printable Registration Form
Register three individuals from the same company and receive complimentary registration for a fourth! All four individuals must register and prepay at the same time – no exceptions. DIA will apply the value of the lowest applicable fee to this complimentary registration; it does NOT include fees for optional events or DIA membership. You may substitute group participants of the same membership status at any time; however, administrative fees may be incurred.
Group registration is not available online and does not apply to the already-discounted fees for government or charitable nonprofit/academia. To take advantage of this offer, please print a registration form for EACH of the four registrants from your company. Include the names of all four group registrants on each of the forms and return them together to DIA.
Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.